This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A Pattern to Link Adenosine Signaling, Circadian System, and Potential Final Common Pathway in the Pathogenesis of Major Depressive Disorder
Molecular Neurobiology Open Access 23 August 2022
-
The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
CNS Drugs Open Access 13 July 2022
-
Association of serum uric acid levels with suicide risk in female patients with major depressive disorder: a comparative cross-sectional study
BMC Psychiatry Open Access 29 September 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
KrĂ¼gel U. Purinergic receptors in psychiatric disorders. Neuropharmacology. 2016;104:212–25.
Ortiz R, Ulrich H, Zarate CA Jr, Machado-Vieira R. Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics. Prog Neuropsychopharmacol Biol Psychiatry. 2015;57:117–31.
Cheffer A, Castillo ARG, CorrĂªa-Velloso J, Gonçalves MCB, Naaldijk Y, Nascimento IC, et al. Purinergic system in psychiatric diseases. Mol Psychiatry. 2018;23:94–106.
El Yacoubi M, Ledent C, Parmentier M, Bertorelli R, Ongini E, Costentin J, et al. Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice. Br J Pharmacol. 2001;134:68–77.
Yamada K, Kobayashi M, Kanda T. Involvement of adenosine A2A receptors in depression and anxiety. Int Rev Neurobiol. 2014;119:373–93.
Cunha GM, Canas PM, Oliveira CR, Cunha RA. Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience. 2006;141:1775–81.
Kaster MP, Machado NJ, Silva HB, Nunes A, Ardais AP, Santana M, et al. Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. Proc Natl Acad Sci USA. 2015;112:7833–8.
Lucas M, O’Reilly EJ, Pan A, Mirzaei F, Willett WC, Okereke OI, Ascherio A. Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults. World J Biol Psychiatry. 2014;15:377–86.
ElgĂ¼n S, Keskinege A, Kumbasar H. Dipeptidyl peptidase IV and adenosine deaminase activity. Decrease in depression. Psychoneuroendocrinology. 1999;24:823–32.
Bartoli F, Trotta G, Crocamo C, Malerba MR, Clerici M, Carrà G. Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression. Eur Arch Psychiatry Clin Neurosci. 2018;268:119–27.
Hines DJ, Schmitt LI, Hines RM, Moss SJ, Haydon PG. Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling. Transl Psychiatry. 2013;3:e212.
Kaster MP, Rosa AO, Rosso MM, Goulart EC, Santos AR, Rodrigues AL. Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors. Neurosci Lett. 2004;355:21–4.
van Heeringen K, Mann JJ. The neurobiology of suicide. Lancet Psychiatry. 2014;1:63–72.
Ernst C, Mechawar N, Turecki G. Suicide neurobiology. Prog Neurobiol. 2009;89:315–33.
Sutin AR, Cutler RG, Camandola S, Uda M, Feldman NH, Cucca F, Zonderman AB, Mattson MP, Ferrucci L, Schlessinger D, Terracciano A. Impulsivity is associated with uric acid: evidence from humans and mice. Biol Psychiatry. 2014;75:31–7.
Bartoli F, Crocamo C, Mazza MG, Clerici M, Carrà G. Uric acid levels in subjects with bipolar disorder: a comparative meta-analysis. J Psychiatr Res. 2016;81:133–9.
Oliveros A, Cho CH, Cui A, Choi S, Lindberg D, Hinton D, Jang MH, Choi DS. Adenosine A2A receptor and ERK-driven impulsivity potentiates hippocampal neuroblast proliferation. Transl Psychiatry. 2017;7:e1095.
Deshpande G, Baxi M, Witte T, Robinson JL. A neural basis for the acquired capability for suicide. Front Psychiatry. 2016;7:125.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Bartoli, F., Clerici, M. & Carrà , G. Purinergic system and suicidal behavior: exploring the link between adenosine A2A receptors and depressive/impulsive features. Mol Psychiatry 25, 512–513 (2020). https://doi.org/10.1038/s41380-018-0057-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-018-0057-x
This article is cited by
-
Therapeutic Potential of the Purinergic System in Major Depressive Disorder Associated with COVID-19
Cellular and Molecular Neurobiology (2023)
-
The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
CNS Drugs (2022)
-
A Pattern to Link Adenosine Signaling, Circadian System, and Potential Final Common Pathway in the Pathogenesis of Major Depressive Disorder
Molecular Neurobiology (2022)
-
Scrutinizing the Therapeutic Promise of Purinergic Receptors Targeting Depression
Neurotoxicity Research (2022)
-
Association of serum uric acid levels with suicide risk in female patients with major depressive disorder: a comparative cross-sectional study
BMC Psychiatry (2020)